NCT00066651View on ClinicalTrials.gov

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2003

Conditions
Cervical CancerFallopian Tube CancerHead and Neck CancerLung CancerMalignant MesotheliomaOvarian CancerPancreatic CancerPrimary Peritoneal Cavity Cancer
Interventions
BIOLOGICAL

SS1(dsFv)-PE38 immunotoxin

Trial Locations (2)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

27157-1096

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00066651 - Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter